Skip to content
ClinCalc Pro
Menu
Anticonvulsant / Perioperative Analgesic Adjunct

Pregabalin (Perioperative)

Brand names: Lyrica

Perioperative pregabalin has been used as an adjunct in multimodal analgesia with the aim of reducing acute post-operative pain and opioid requirements, though routine use is now more cautious.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Pregabalin binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing presynaptic release of excitatory neurotransmitters involved in pain signalling.

Prescribing in practice

  • Sedation and respiratory depression are additive with opioids and other CNS depressants in the perioperative period — the combination increases the risk of excessive sedation and breathing problems, so co-prescribe and monitor carefully, especially in the elderly.
  • Reduce the dose in renal impairment, as pregabalin is renally cleared and accumulates.
  • Pregabalin is a controlled drug with recognised misuse potential; avoid abrupt discontinuation after prolonged use and weigh the limited analgesic benefit against harms.

Monitoring

Monitor sedation, respiratory status and pain scores when combined with opioids, with particular vigilance in older or renally impaired patients.

Counselling the patient

  • This medicine may be used to help with pain around surgery and to reduce the need for strong painkillers.
  • It can make you drowsy or dizzy, especially with other painkillers.
  • Do not stop it suddenly if you have been taking it regularly.

Evidence & guidelines

Evidence for perioperative gabapentinoids shows modest opioid-sparing offset by sedation, and routine use is no longer broadly endorsed.

Reference: MHRA Drug Safety Update 2017; PROSPECT Guidelines; Doleman et al. (2015) meta-analysis; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.